SkyDance Vascular, Inc.

SkyDance Vascular manufactures the OspreyIV, a proprietary through-the-needle peripheral vascular access device designed to address complications associated with traditional over-the-needle catheters. The OspreyIV features four core innovations: (1) Skin Avoidance Technology—the catheter passes through rather than over the needle, preventing skin contact and reducing infection risk from bacterial colonization; (2) Bevel Only Technique—enabling single-attempt insertion success and minimizing vessel trauma and phlebitis; (3) Passive Needle Retraction—automatic needle retraction into housing post-insertion, eliminating sharps handling and needlestick injury risk; and (4) Contoured Directional Flow—off-axis fluid delivery away from the venous wall to reduce infiltration, phlebitis, and chemical irritation. The OspreyIV product line includes peripheral IV, peripheral closed IV, and midline closed IV catheter systems. Aligned with Aseptic Non-Touch Technique (ANTT) principles, the technology is designed to reduce catheter-related bloodstream infections (estimated 200,000 annually in the U.S., costing ~$6B), vessel damage, and clinical complications across adult, pediatric, and neonatal populations. B2B-focused supplier for hospitals, health systems, and acute-care facilities.